All In Biotech

Drug Trial Radar · NCT07265570

Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)

A Phase IIa, Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of ISM5411 in Adult Patients With Active Ulcerative Colitis

Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Dec 10, 2025

Primary completion

Aug 15, 2027

Study completion Aug 30, 2027

Sponsor

Sponsor type
Industry
First posted
Dec 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and clinical efficacy of ISM5411 in adult patients with active ulcerative colitis.

Conditions

  • Ulcerative Colitis

Interventions

  • ISM5411 tabletsDrug

    Dosage Form: Tablet; Frequency of administration: Orally QD.

  • ISM5411 tabletsDrug

    Dosage Form: Tablet; Frequency of administration: Orally QD.

  • ISM5411 tabletsDrug

    Dosage Form: Tablet ; Frequency of administration: Orally QD.

  • PlaceboDrug

    Dosage Form: Tablet; Frequency of administration: Orally QD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The rate of treatment-emergent adverse events (TEAEs) in each group.Time frame: Week1 to Week12.
  2. The rate of serious adverse events (SAEs) and adverse events (AEs) leading to discontinuation of treatment in each group.Time frame: Up to 16 weeks.
  3. Changes and comparisons of the following data for each group of subjects: vital signs, physical examination, laboratory test(blood routine, blood chemistry, urinalysis, coagulation function, etc.), ECG(Heart rate, RR, PR, QRS,QT, QTcF ), etc.Time frame: Up to 16 weeks.

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • The First Affiliated Hospital,Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • Huizhou First Hospital

    Huizhou, Guangdong, China · Recruiting

  • The People's Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China · Recruiting

  • The Second Hospital of HeBei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • The First Affiliated Hospital of Henan University of Science & Technology

    Luoyang, Henan, China · Recruiting

  • The First Affiliated Hospital of Xinxiang Medical University

    Xinxiang, Henan, China · Recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China · Recruiting

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • The First Affiliated Hospital of University of South China

    Hengyang, Hunan, China · Recruiting

  • ZhongDa Hospital Southeast University

    Nanjing, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Gannan Medical University

    Ganzhou, Jiangxi, China · Recruiting

  • Meihekou Central Hospital

    Tonghua, Jilin, China · Recruiting

  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, China · Recruiting

  • Binzhou Medical University Hospital

    Binzhou, Shandong, China · Recruiting

  • Tai 'an City Central Hospital

    Taian, Shandong, China · Recruiting

  • Longhua Hospital Shanghai University of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Renji Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China · Recruiting

  • Xi'an Central Hospital

    Xian, Shanxi, China · Recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China · Recruiting

  • West China School of Medicine and West China Hospital Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Tianjin People's Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, China · Recruiting

  • Lishui Central Hospital

    Lishui, Zhejiang, China · Recruiting

  • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.